Medical management of a suspected atrial myxoma in a nonagenarian

Kawall, Jessica; Seecheran, Rajeev; Seecheran, Valmiki; Persad, Sangeeta; Maharaj, Stefan; Seecheran, Naveen

doi:10.1177/2050313x20933484

Cited by 2 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The standard treatment of CM is surgical resection. With increasing life expectancy, however, the incidence of myxomas is rising in the elderly, creating challenges for surgical treatment [ 8 , 15 ]. A recent study reported about 25% mortality in the geriatric population undergoing cardiac surgery with a mean age of ~69±4 years at the time of surgery [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Asymptomatic Pulmonic Valve Mass: A Diagnostic and Therapeutic Dilemma

Khan¹,

Asif²,

Nadeem³

et al. 2023

Cureus

View full text Add to dashboard Cite

Cardiac masses are not common but remain important in cardiology practice as they can cause havoc to a patient's life through obstructive and arrhythmogenic symptoms. These lesions mostly include vegetation, thrombi, and tumors. Myxomas are the most common primary cardiac tumor, primarily arising from the left heart chambers. It is exceedingly rare for a myxoma to emerge from the right-sided cardiac valves. The standard treatment is surgical resection, regardless of size, which is not always possible. We report a unique case of a male with multiple co-morbidities who presented with an incidental finding of a pulmonary valve mass suspicious of being a myxoma. The myxomatous mass was asymptomatic with no right ventricular outflow tract obstruction. Echocardiogram can help identify and characterize these lesions, but this may not be easy, especially in the case of atypical location or morphology of the mass. Similarly, in some cases, the patient may not be able to undergo surgical excision. In such cases, there is no consensus or guidelines to help clinicians best manage the patients medically, creating a diagnostic and therapeutic dilemma.

show abstract

Section: Discussionmentioning

confidence: 99%

“…It was unclear whether they were treated with anticoagulation or antiplatelets [ 18 ]. A recent case report described a patient who survived three months on apixaban without any complications [ 15 ].…”

Section: Discussionmentioning

confidence: 99%

Asymptomatic Pulmonic Valve Mass: A Diagnostic and Therapeutic Dilemma

Khan¹,

Asif²,

Nadeem³

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…The clinical manifestations of the tumor are determined by its size, location, surface, and mobility ( 1 , 3 ). Dyspnea (70%) and palpitation (35%) have been reported to be the most familiar symptoms ( 4 , 12 ). An embolism caused by myxoma may result in myocardial infarction ( 13 ).…”

Section: Discussionmentioning

confidence: 99%

“…It most commonly affects females between the ages of 40 and 60 ( 2 , 3 ). Generally, myxoma develops in the left atrium (LA), followed by the right atrium (RA) ( 4 , 5 ). This tumor usually develops from the atrial septum near the fossa ovalis, but it can rarely develop from the posterior wall, anterior wall, or left atrial appendage ( 6 ).…”

Section: Introductionmentioning

confidence: 99%

“…This tumor usually develops from the atrial septum near the fossa ovalis, but it can rarely develop from the posterior wall, anterior wall, or left atrial appendage ( 6 ). Based on the location, this neoplasm may be asymptomatic or can cause embolization or intracardiac obstruction, which results in heart failure, sudden cardiac death, and arrhythmia ( 4 ). However, surgical intervention has become the standard modality to manage cardiac myxoma, but intraoperative embolization and recurrence are the major complications ( 7 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Operative management and outcomes in patients with myxomas: A single-center experience

Alhasso¹,

Ahmed

Mohammed-Saeed

et al. 2023

Front. Surg.

View full text Add to dashboard Cite

BackgroundCardiac myxoma is a rare cardiac tumor that may be asymptomatic or can cause embolization or intracardiac obstruction, leading to heart failure, sudden cardiac death, and arrhythmia. This study aims to report an 11-year experience of a single center in the management of cardiac myxoma.MethodThis study is a single-center retrospective case series. Eighty cases of cardiac myxoma were collected in Ibn Albitar's specialized center for cardiac surgery. Transthoracic echocardiography was used to make the preoperative diagnosis in all patients. The surgeries were undertaken through the standard approach of a median sternotomy. All four cardiac chambers were thoroughly explored for additional myxomas. The major objective of the operations was complete tumor resection.ResultThe mean age of the patients was 46.3 years. Females (67.5%) were predominant over males (32.5%). Shortness of breath was the most common symptom (86.25%). The left atrium was the most affected site (83.75%), followed by the right atrium (13.75%). Coronary artery bypass grafting was required as the secondary or associated intervention in 19 (23.75%) cases. The recurrence rate was 11.25%, with a mortality rate of 3.75%.ConclusionRecurrence and tumor embolism are risks of surgical intervention for myxoma. Good preparation using transthoracic echocardiography as a diagnostic tool and standard median sternotomy to complete resection of the tumors can decrease the rate of recurrence, embolism, and even mortality.

show abstract

Medical management of a suspected atrial myxoma in a nonagenarian

Cited by 2 publications

References 26 publications

Asymptomatic Pulmonic Valve Mass: A Diagnostic and Therapeutic Dilemma

Asymptomatic Pulmonic Valve Mass: A Diagnostic and Therapeutic Dilemma

Operative management and outcomes in patients with myxomas: A single-center experience

Contact Info

Product

Resources

About